Role of MRI in Active Surveillance of Prostate Cancer

被引：0

作者：

Chappidi, Meera R. ^{[1
]}

Lin, Daniel W. ^{[1
]}

Westphalen, Antonio C. ^{[1
,2
,3
]}

机构：

[1] Univ Washington, Sch Med, Dept Urol, Seattle, WA USA

[2] Univ Washington, Sch Med, Dept Radiol, 1959 NE Pacific St, Seattle, WA 98195 USA

[3] Univ Washington, Sch Med, Dept Radiat Oncol, Seattle, WA USA

来源：

SEMINARS IN ULTRASOUND CT AND MRI | 2025年 / 46卷 / 01期

关键词：

CLINICAL STAGE; MEN; BIOPSY; PROGRESSION; OUTCOMES;

D O I：

10.1053/j.sult.2024.11.002

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Magnetic resonance imaging (MRI) plays an important role in the management of patients with prostate cancer on active surveillance. In this review, we will explore the incorporation of MRI into active surveillance protocols, detailing its impact on clinical decision-making and patient management and discussing how it aligns with current guidelines and practice patterns. The role of MRI in this patient population continues to evolve over time, and we will discuss some of the recent advancements in the field and highlight potential areas for future research endeavors.

引用

页码：31 / 44

页数：14

共 50 条

[41] Active surveillance in prostate cancer: Assessment of MRI in the selection and follow-up of patients
Raichi, A.
Marcq, G.
Fantoni, J. C.
Puech, P.
Villers, A.
Ouzzane, A.
PROGRES EN UROLOGIE, 2018, 28 (8-9): : 416 - 424
[42] The PRECISE Recommendations for Prostate MRI in Patients on Active Surveillance for Prostate Cancer: A Critical Review
Sanmugalingam, Nimalan
Sushentsev, Nikita
Lee, Kang-Lung
Caglic, Iztok
Englman, Cameron
Moore, Caroline M.
Giganti, Francesco
Barrett, Tristan
AMERICAN JOURNAL OF ROENTGENOLOGY, 2023, 221 (05) : 649 - 660
[43] ERG and PTEN Role on Active Surveillance for Low-Risk Prostate Cancer in the Multiparametric MRI Era
Yorioka, Marco Aurelio Watanabe
Murta, Claudio Bovolenta
Leite, Katia Ramos Moreira
Cardili, Leonardo
de Mello, Evandro Sobroza
Fazoli, Arnaldo Jose de Carvalho
Cordeiro, Mauricio Dener
Coelho, Rafael Ferreira
Viana, Publio Cesar Cavalcante
Kohama, Cesar Sadao Nicolino
Nahas, William Carlos
Pontes-Junior, Jose
PROSTATE, 2025, 85 (04) : 364 - 373
[44] Active surveillance for prostate cancer: when to recommend delayed intervention
Babaian, Kara N.
ASIAN JOURNAL OF ANDROLOGY, 2015, 17 (06) : 885 - 887
[45] The importance of PSA-Density in active surveillance for prostate cancer
Ediz, Caner
Akan, Serkan
Temel, Muhammed Cihan
Yilmaz, Omer
ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2020, 92 (02) : 136 - 141
[46] Active surveillance in prostate cancer: patient selection and triggers for intervention
Lees, Kathryn
Durve, Meeta
Parker, Chris
CURRENT OPINION IN UROLOGY, 2012, 22 (03) : 210 - 215
[47] Active surveillance for low-risk prostate cancer: an update
Lawrentschuk, Nathan
Klotz, Laurence
NATURE REVIEWS UROLOGY, 2011, 8 (06) : 312 - 320
[48] Active surveillance for the management of localized prostate cancer: Guideline recommendations
Morash, Chris
Tey, Rovena
Agbassi, Chika
Klotz, Laurence
McGowan, Tom
Srigley, John
Evans, Andrew
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2015, 9 (5-6): : 171 - 178
[49] The management of active surveillance in prostate cancer: validation of the Canary Prostate Active Surveillance Study risk calculator with the Spanish Urological Association Registry
Borque-Fernando, Angel
Rubio-Briones, Jose
Mariano Esteban, Luis
Collado-Serra, Argimiro
Pallas-Costa, Yoni
Angel Lopez-Gonzalez, Pedro
Huguet-Perez, Jorge
Ignacio Sanz-Velez, Jose
Manuel Gil-Fabra, Jesus
Gomez-Gomez, Enrique
Quicios-Dorado, Cristina
Fumado, Lluis
Martinez-Breijo, Sara
Soto-Villalba, Juan
ONCOTARGET, 2017, 8 (65) : 108451 - 108462
[50] Active surveillance in prostate cancer
Erne, E.
Kaufmann, S.
Nikolaou, K.
Stenzl, A.
Bedke, J.
UROLOGE, 2019, 58 (05): : 511 - 517

← 1 2 3 4 5 →